• Income Statement
• Balance Sheet
• Cash Flow
• Ratios
• Market Data
• Valuation

	AVAI BIO, INC. (TREN)
	Q3-CY2026	Q2-CY2026	Q1-CY2026	Q4-CY2025	Q3-CY2025	Q2-CY2025	Q1-CY2025	Q4-CY2024	Q3-CY2024	Q2-CY2024	Q1-CY2024	Q4-CY2023	Q3-CY2023	Q2-CY2023	Q1-CY2023	Q4-CY2022	Q3-CY2022	Q2-CY2022	Q1-CY2022	Q4-CY2021	Q3-CY2021	Q2-CY2021	Q1-CY2021	Q4-CY2020	Q3-CY2020	Q2-CY2020	Q1-CY2020	Q4-CY2019	Q3-CY2019	Q2-CY2019	Q1-CY2019	Q4-CY2018	Q3-CY2018	Q2-CY2018	Q1-CY2018	Q4-CY2017	Q3-CY2017	Q2-CY2017	Q1-CY2017	Q4-CY2016	Q3-CY2016	Q2-CY2016	Q1-CY2016	Q4-CY2015	Q3-CY2015	Q2-CY2015	Q1-CY2015	Q4-CY2014	Q3-CY2014
Balance Sheet Date			2026-Mar-31	2025-Dec-31	2025-Sep-30	2025-Jun-30	2025-Mar-31	2024-Dec-31	2024-Sep-30	2024-Jun-30	2024-Mar-31	2023-Dec-31												2020-Dec-31	2020-Sep-30	2020-Jun-30	2020-Mar-31	2019-Dec-31	2019-Sep-30	2019-Jun-30	2019-Mar-31	2018-Dec-31	2018-Sep-30	2018-Jun-30
Fiscal Period			Q4-FY2026	Q3-FY2026	Q2-FY2026	Q1-FY2026	Q4-FY2025	Q3-FY2025	Q2-FY2025	Q1-FY2025	Q4-FY2024	Q3-FY2024												Q3-FY2021	Q2-FY2021	Q1-FY2021	Q4-FY2020	Q3-FY2020	Q2-FY2020	Q1-FY2020	Q4-FY2019	Q3-FY2019	Q2-FY2019	Q1-FY2019
Total Revenue				(43,953$)	(58,350$)		425,626$	(23,400$)	0$	(11,549$)						142,375$													0$				0$
QoQ%				24.67%			1,918.92%	.00%	100.00%
YoY%				(87.83%)	.00%																								.00%
Cost Of Revenue				0$	0$		3,837$	0$	5,499$	5,499$		10,267$			0$	213,912$								500,976$	267,211$	214,582$	461,116$	0$	0$	0$	0$	0$	0$
Gross Profit				(43,953$)	(58,350$)		421,789$	(23,400$)	(5,499$)	(17,048$)		(10,267$)			1$	(71,537$)								(346,194$)	87,392$	84,631$	250,334$	0$	0$	6,000$	0$	0$	0$	0$
Gross Margin				100.00%	100.00%		99.10%	100.00%		147.62%						(50.25%)
Operating Expenses			88,162$	509,774$	394,666$	487,589$	(38,446$)	428,898$	623,046$	517,294$	303,432$	1,013,900$	388,328$	411,522$	572,929$	(182,008$)								70,960$	37,018$	33,554$	236,883$	10,165$	30,993$	20,696$	26,696$	19,573$	26,716$	6,198$
Operating Income			(255,177$)	(553,727$)	(453,016$)	(487,589$)	(2,748,302$)	452,298$	623,046$	(528,843$)	(3,953,518$)	1,013,900$			(572,928$)	110,471$											13,451$				(26,696$)
Operating Margin				1,259.82%	776.38%		(645.71%)	(1,932.90%)		4,579.12%						77.59%
Interest Income
Interest Expenses																0$
Income Before Tax			(255,177$)	(553,727$)	(453,016$)	(487,589$)	(2,748,302$)	(452,298$)	(623,046$)	(528,843$)	(3,953,518$)	(1,013,900$)	(399,621$)	(411,522$)	(124,938$)	(110,471$)	(83,762$)	(29,762$)						(417,163$)	50,462$	51,077$	13,451$	(10,165$)	(30,993$)	(14,696$)	(26,696$)	(19,573$)	(24,175$)	(6,198$)
Tax Expenses																																0$
Net Income			(255,177$)	(553,727$)	(453,016$)	(487,589$)	(2,748,302$)	(452,298$)	(623,046$)	(528,843$)	(3,953,518$)	(1,013,900$)	(399,621$)	(411,522$)	(124,938$)	(110,471$)	(83,762$)	(29,762$)						(417,163$)	50,462$	51,077$	13,451$	(10,165$)	(30,993$)	(14,696$)	(26,696$)	(19,573$)	(24,175$)	(6,198$)
Profit Margin				1,259.82%	776.38%		(645.71%)	1,932.90%		4,579.12%						(77.59%)
TTM							(1,114.09%)
Earnings to Minority							(3,212,374$)	(904,596$)	(1,246,092$)		(3,650,086$)																			27,190$	2,148$	(565$)	(43$)
Earnings to Common Shareholders			(255,177$)	(553,727$)	(453,016$)	(487,589$)	(2,748,302$)	452,298$	623,046$	(528,843$)	(303,432$)	(1,013,900$)	(399,621$)	(411,522$)	(124,938$)	(110,471$)	(83,762$)	(29,762$)						(417,163$)	50,462$	51,077$	13,451$	(10,165$)	(30,993$)	(41,886$)	(28,844$)	(19,008$)	(24,132$)	(6,198$)
QoQ%			53.92%	(22.23%)	7.09%	82.26%	(707.63%)	(27.41%)	217.81%	(74.29%)	70.07%	(153.72%)	2.89%	(229.38%)	(13.10%)	(31.89%)	(181.44%)							(926.69%)	(1.20%)	279.73%	232.33%	67.20%	26.01%	(45.22%)	(51.75%)	21.23%	(289.34%)
YoY%			90.72%	(222.43%)	(172.71%)	7.80%	(805.74%)	144.61%	255.91%	(28.51%)	(142.87%)	(817.80%)	(377.09%)	(1,282.71%)										(4,003.92%)	262.82%	221.94%	146.63%	46.52%	(28.43%)	(575.78%)
Earnings Per Share, Basic			0.00$	0.00$	0.00$	0.00$	(0.02$)	0.00$	0.01$	0.00$	0.00$	(0.01$)	(0.01$)	(0.01$)		0.00$
Earnings Per Share, Diluted																								(0.02$)	0.00$	0.00$	0.00$	0.00$	(0.01$)	(0.01$)	0.00$	0.00$	(0.01$)	0.00$
Unlevered FCF Per Share, Basic			0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	(0.01$)	0.00$	0.00$		(0.01$)	0.00$
Unlevered FCF Per Share, Diluted																								0.00$	0.00$	0.00$	(0.01$)	0.01$	0.00$	0.00$	0.00$	0.00$	(0.03$)	0.00$
Average Shares, Basic			138,780,408	138,029,337	137,624,709	137,462,534	136,155,930	137,004,635	123,604,231	115,827,600	139,373,601	74,840,737	74,267,054	57,646,668		32,231,083
Average Shares, Diluted																								26,281,600	26,281,600	26,281,600	-10,972,260	5,014,080	5,014,080	5,014,080	7,537,095	5,014,080	2,234,536	3,763,441
EBIT			(255,177$)	(553,727$)	(453,016$)	(487,589$)	(2,748,302$)	(452,298$)	(623,046$)	(528,843$)	(3,953,518$)	(1,013,900$)	(399,621$)	(411,522$)	(124,938$)	(110,471$)	(83,762$)	(29,762$)						(417,163$)	50,462$	51,077$	13,451$	(10,165$)	(30,993$)	(14,696$)	(26,696$)	(19,573$)	(24,175$)	(6,198$)
EBITDA			(248,659$)	(547,210$)	(446,499$)	(481,071$)	(2,732,535$)	(432,780$)	(603,528$)	(509,326$)	(3,906,251$)	(1,003,632$)	(389,304$)	(402,421$)	(124,938$)	(110,471$)	(83,762$)	(29,762$)						(403,039$)	64,510$	65,536$	32,361$	(1,973$)	(21,158$)	(14,621$)	(24,531$)	(17,408$)	(23,703$)	(6,198$)

Copy Table ✓